Search for: "FOREST PRODUCTS V US" Results 521 - 540 of 585
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2009, 1:02 pm
Trex and Snavely Forest Products and Home Depot (CAFC 2009-1026) precedential Home Depot and Snavely Forest Products are distributors of Trex products. [read post]
4 Sep 2009, 12:11 am
Of infringement:A patentee may prove infringement by "any method of analysis that is probative of the fact of infringement," Forest Labs. v. [read post]
3 Sep 2009, 8:25 pm
The patents at issue relate to specified microorganisms that are useful for the commercial production of DHA because they produce high levels of DHA. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
9 Jul 2009, 3:03 pm
 Ineligible projects include those that use the following feedstocks: municipal solid waste, wood from old growth forests, and chemically treated wood. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi… [read post]
30 May 2009, 12:29 pm
United States Forest Service, et al. [read post]
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs)   General Blockbusters and other strategies (IP Think Tank) AU - TRIPS, Pharmaceuticals and Manufacture for Export - IP Think Tank Podcast (IP Think Tank) Germany: Open fight on biotechnology, patents, and CIIs (IP Jur) US - It’s not an invention if you use conventional techniques to make it (Patent Baristas) US - Debate on creating a regulatory pathway for approval of follow-on biologics (FOB)… [read post]
27 Feb 2009, 5:00 am
(Patent Baristas) US: Teva releases second video in year of affordable healthcare campaign (SmartBrief) US: Discussion of NYT article ‘Crop Scientists Say Biotechnology Seed Companies are Thwarting Research’ (Patent Docs) (Patent Baristas) US FDA: Genetically engineered organisms can be patented (RelatIP) US: Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo seeks review and correction of patent term adjustment for patent covering… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to… [read post]